Filing Details

Accession Number:
0001179110-11-015802
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-11-30 19:44:10
Reporting Period:
2011-11-28
Filing Date:
2011-11-30
Accepted Time:
2011-11-30 19:44:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1080014 Theravance Inc THRX Pharmaceutical Preparations (2834) 943265960
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1302448 J Bradford Shafer Theravance, Inc.
901 Gateway Boulevard
South San Francisco CA 94080
Sr Vp, Gen. Counsel, Secretary No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-11-28 14,076 $8.53 354,544 No 4 M Direct
Common Stock Acquisiton 2011-11-28 16,129 $8.53 370,673 No 4 M Direct
Common Stock Disposition 2011-11-28 20,000 $21.00 350,673 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2011-11-28 14,076 $0.00 14,076 $8.53
Common Stock Stock Option (Right to Buy) Disposition 2011-11-28 16,129 $0.00 16,129 $8.53
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2012-02-24 No 4 M Direct
0 2012-02-24 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 2,750 Indirect by child's trust
Common Stock 2,750 Indirect by child's trust
Common Stock 2,750 Indirect by child's trust
Footnotes
  1. Dispositions made pursuant to a plan intended to comply with rule 10b5-1(c).
  2. This transaction was executed in multiple trades at prices from $21.00 to $21.01. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
  3. Shares held in trust for the benefit of a child of the reporting person. Reporting person is a trustee of the trust. Reporting person disclaims beneficial ownership of these shares.
  4. Exercisable immediately.